Healthcare Biz Cheat Sheet: Transcept Gets FDA Approval for Intermezzo, Express Scripts Files Lawsuit Against Walgreen

Transcept Pharmaceutials (NASDAQ:TSPT) shares are soaring today following the company’s announcement yesterday that the FDA was “generally” on board with its Intermezzo drug.

Hot Feature: Groupon to Investors: Just Ignore Our Accounting, SEC Violation, and Competitors

HCA Holdings (NYSE:HCA) is leading hospital stocks upward today following a share repurchasement announcement. Tenet Healthcare (NYSE:THC) and Community Health Systems (NYSE:CYH) are also moving higher, as investors focus on earnings and valuation rather than takeover chatter.

Vivus (NASDAQ:VVUS) shares popped today after the FDA agreed to allow an early resubmission of its new drug application for Qnexa, a treatment for obesity. Vivus will resubmit the application for Qnexa by the end of October.

Infosys (NASDAQ:INFY) is in talks to acquire Thomson Reuters’ healthcare business for $700 million to $750 million. The Thomson Reuters unit supplies healthcare data and analysis to companies, government agencies, and health professionals.

Don’t Miss: U.S. Gas Imports Expected to Decline 5% in September

Express Scripts (NASDAQ:ESRX) has filed a lawsuit against Walgreen Company (NYSE:WAG) for allegedly using false advertising to lure Medicare patients away. Back in June, Walgreen opted out of Express Script’s pharmacy network after contract re-negotiations between the two broke down.